Age onset | Clinical features | HLA B27 | Acute Phase Reactants at onset | Initial treatment | First DMARD | Anti-TNF | Remission time prior to dosage reduction | Total time under anti-TNF dosage reduction | |
---|---|---|---|---|---|---|---|---|---|
1 | 13 | Peripheral (polyarthritis, enthesitis, dactylitis) | + | raised | NSAID, steroids | methotrexate | etanercept | 57 | 9 |
2 | 14 | Mixed (olygoarthritis, sacroilitis) | + | raised | NSAID, steroid intrarticular injection | methotrexate | etanercept | 12 | 6 |
3 | 11 | Peripheral (enthesitis, monoarthritis) | + | normal | NSAIDD, steroid intrarticular injection | SSZ, methotrexate | etanercept | 24 | 6 |
4 | 11 | Mixed (olygoarthritis, sacroilitis) | + | normal | NSAID, steroid intrarticular injection | methotrexate, SSZ | adalimumab | 12 | 5 |